36.30
0.42 (1.17%)
| Previous Close | 35.88 |
| Open | 35.92 |
| Volume | 61,497 |
| Avg. Volume (3M) | 597,309 |
| Market Cap | 1,049,553,344 |
| Price / Sales | 5.02 |
| Price / Book | 16.10 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2025 - 8 Aug 2025 |
| Profit Margin | -50.95% |
| Operating Margin (TTM) | -41.94% |
| Diluted EPS (TTM) | -2.96 |
| Quarterly Revenue Growth (YOY) | 41.00% |
| Total Debt/Equity (MRQ) | 424.32% |
| Current Ratio (MRQ) | 3.56 |
| Operating Cash Flow (TTM) | -58.52 M |
| Levered Free Cash Flow (TTM) | -37.94 M |
| Return on Assets (TTM) | -10.15% |
| Return on Equity (TTM) | -236.66% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | Establishment Labs Holdings Inc | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | 2.0 |
| Average | 2.13 |
|
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing silicone-filled breast and body shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Growth |
| % Held by Insiders | 11.26% |
| % Held by Institutions | 103.39% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Tyro Capital Management Llc | 31 Mar 2025 | 1,063,886 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 52.00 (Stephens & Co., 43.27%) | Buy |
| Median | 50.00 (37.76%) | |
| Low | 48.00 (Needham, 32.25%) | Buy |
| Average | 50.00 (37.76%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 39.27 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Needham | 14 May 2025 | 48.00 (32.25%) | Buy | 36.46 |
| Stephens & Co. | 06 Mar 2025 | 52.00 (43.27%) | Buy | 42.08 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 07 May 2025 | Announcement | Establishment Labs Reports First Quarter 2025 Financial Results |
| 07 May 2025 | Announcement | Establishment Labs Appoints Peter Caldini as Chief Executive Officer |
| 24 Apr 2025 | Announcement | Establishment Labs to Announce First Quarter 2025 Financial Results on May 7 |
| 10 Apr 2025 | Announcement | Establishment Labs Provides Preliminary First Quarter Results and Announces an Investor Day on June 12 |
| 20 Mar 2025 | Announcement | Establishment Labs Notes Presentation of 5-Year Results from Motiva U.S. IDE Study at The Aesthetic MEET 2025 |
| 06 Mar 2025 | Announcement | Establishment Labs® Announces Meghan Trainor as Brand Partner Following Her Breast Augmentation with Motiva Implants® |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |